The goal of this observational study is to learn whether a digital angiography derived fractional flow reserve (DPR) measurement can improve the prediction of stroke risk in adults with symptomatic intracranial atherosclerotic stenosis, defined as 50 to 99 percent narrowing. The main questions it aims to answer are: Does DPR identify patients who are at higher risk of recurrent stroke despite receiving standard medical treatment? Is DPR more accurate than traditional angiographic stenosis measurements for assessing the functional severity of intracranial arterial disease? Participants will undergo routine digital subtraction angiography as part of their clinical evaluation. Their angiographic images will be analyzed using a computational method to estimate blood flow impairment, and they will be followed for up to 12 months to monitor stroke related outcomes.
Intracranial atherosclerotic stenosis (ICAS) is a major cause of ischemic stroke, representing \~15% of cases in Western populations and up to 46.6% in Asia. Even with intensive medical therapy, annual stroke recurrence remains high (7.2-20%), prompting exploration of additional treatment strategies. Early trials such as SAMMPRIS and VISSIT suggested worse outcomes with stenting compared with aggressive medical therapy, largely due to concerns over operator experience, patient selection, and timing. Subsequent analyses showed that patients with hemodynamic compromise-such as watershed infarction and poor collaterals-have recurrence rates up to 37%, underscoring the central role of impaired cerebral perfusion. Although more recent studies (CASSISS, BASIS) demonstrated that endovascular therapy may be safe and effective in carefully selected patients, current ICAS assessment relies primarily on stenosis severity, which correlates only weakly with true hemodynamic impairment and is insufficient for accurate risk stratification. Because symptoms arise principally from reduced perfusion, physiologic evaluation is essential. Fractional flow reserve (FFR) is the gold standard for assessing coronary lesion significance and guiding intervention through translesional pressure gradients. Attempts to translate this approach to ICAS using invasive pressure wires have shown feasibility but remain limited by anatomical differences, lack of dedicated devices, procedural risks, and unclear outcome thresholds. Our prior work demonstrated that intracranial translesional pressure gradients correlate strongly with cerebral blood flow in both animal models and clinical settings, validating hemodynamic relevance. To overcome the limitations of invasive measurements, the present study seeks to develop and evaluate a noninvasive, angiography-derived pressure ratio (DPR) using routine digital subtraction angiography. This method allows physiologic assessment without pressure wires and may reduce procedural risk. The objectives of this project are to establish a computational DPR technique, determine its association with clinical outcomes, identify a hemodynamic threshold for stroke-risk stratification, and validate its performance in a prospective multicenter cohort. By enabling early identification of high-risk ICAS patients who may respond poorly to medical therapy, DPR has the potential to improve treatment selection and outcomes, ultimately advancing strategies for stroke prevention.
Study Type
OBSERVATIONAL
Enrollment
400
Dual antiplatelet treatment and management of vascular risk factors, in accordance with AHA/ASA guidelines
Department of Neurosurgery, Xuanwu hospital
Beijing, Xicheng District, China
ischemic stroke in the qualifying artery territory or related death within 1 year after enrollment.
the number of participants who suffer from ischemic stroke in the qualifying artery territory or related death within 1 year after enrollment.
Time frame: Baseline to 12 months (±2 months)
transient ischemic attack (TIA) or ischemic stroke in the qualifying artery territory within 1 year
the number of participants who suffer from transient ischemic attack (TIA) or ischemic stroke in the qualifying artery territory within 1 year after enrollment.
Time frame: Baseline to 12 months (±2 months)
TIA related to ischemia in the qualifying artery territory within 1 year
the number of participants who suffer from TIA related to ischemia in the qualifying artery territory within 1 year
Time frame: Baseline to 12 months (±2 months)
any stroke/TIA/ death within 1 year
the number of participants who suffer from any stroke/TIA/ death within 1 year
Time frame: Baseline to 12 months (±2 months)
hemodynamic ischemic stroke in the qualifying artery territory within 1 year
the number of participants who suffer from hemodynamic ischemic stroke in the qualifying artery territory within 1 year
Time frame: Baseline to 12 months (±2 months)
embolic stroke within in the qualifying artery territory 1 year
the number of participants who suffer from embolic stroke within in the qualifying artery territory 1 year
Time frame: Baseline to 12 months (±2 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.